MyFinsight
Home
Blog
About
Contact
Download
Download image
Net comprehensive
loss attributable to...
-$53,941K
Net loss
attributable to common...
-$53,575K
(-39.18%↓ Y/Y)
Translation adjustments
-$366K
Net loss
attributable to...
-$563K
(25.82%↑ Y/Y)
Net loss
-$53,997K
(-37.57%↓ Y/Y)
Deemed dividend to
preferred stockholders
$141K
Loss before income
tax expense
-$53,997K
(-37.57%↓ Y/Y)
Other income
(expense)
$43K
(-15.69%↓ Y/Y)
Product
$11,339K
License
$172K
Loss from operations
-$45,908K
(-48.90%↓ Y/Y)
Changes in fair value of
freestanding and hybrid...
$6,266K
(-33.94%↓ Y/Y)
Gain (loss) on
extinguishment of debt
-$1,799K
(-244.50%↓ Y/Y)
Interest income
(expense)
$67K
(-71.00%↓ Y/Y)
Total revenue, net
$11,511K
(-1.52%↓ Y/Y)
Total operating
expenses
$57,419K
(35.04%↑ Y/Y)
Research and development
$24,966K
(50.92%↑ Y/Y)
General and
administrative
$18,644K
(14.16%↑ Y/Y)
Sales and marketing
$9,235K
(20.06%↑ Y/Y)
Cost of product
revenue
$3,774K
(93.04%↑ Y/Y)
Impairment loss on
indefinite-lived intangible...
$800K
Back
Back
Income Statement
source: myfinsight.com
Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc. (JAGX)